Long COVID in adults – a current review of the long-term health effects following SARS-CoV-2 infection
RKI edoc (Robert Koch-Institut) · 25.02.2026 · 11 · 1-14
DOI: 10.25646/13622 ↗Kurz gefasst
Fachartikel in der Zeitschrift RKI edoc (Robert Koch-Institut), erschienen am 25.02.2026. Verfasst von Julia Nübel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Robert Koch Institute, Department of Epidemiology and Health Monitoring, Berlin, Germany. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Background
Long-term health effects associated with SARS-CoV-2 pose major challenges for public health and health research worldwide.
Methods
Based on an ongoing literature review, a narrative review (as of June 2025) on the epidemiology and public health implications of long COVID in adults was compiled.
Results
According to population-based, controlled studies, long COVID symptoms occur with a frequency of approximately 10 to 15 % in adults infected with SARS-CoV-2. In addition to COVID-19 vaccination status and virus variant, the risk of experiencing long COVID symptoms is primarily influenced by pre-existing health conditions and sociodemographic factors. In most affected individuals, long COVID symptoms resolve within a year. Particularly multiple and prolonged symptoms can be associated with significant impairments in quality of life, everyday functioning and social participation, as well as an increased need for healthcare. In addition, there is growing evidence of an infection-associated increase in newly diagnosed symptom complexes, organ damage and chronic diseases, contributing to the ongoing public health relevance of long COVID.
Conclusions
Long COVID is not only a major burden for those affected and their families, but also has unpredictable long-term consequences for public health and the healthcare system.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Robert Koch Institute, Department of Epidemiology and Health Monitoring, Berlin, Germany.
- Robert Koch Institute, Method Development, Research Infrastructure and Information Technology (MFI), Berlin, Germany.
- Robert Koch Institute, Centre for Biological Threats and Special Pathogens (ZBS), Berlin, Germany.
Zitieren
APA
Nübel, J., Beyer, A. K., Kümpel, L., Eckert, G., Yessimova, D., Heldt, K., Mikolajewska, A., & Sarganas, G. (2026). Long COVID in adults – a current review of the long-term health effects following SARS-CoV-2 infection. RKI edoc (Robert Koch-Institut), 11, 1-14. https://doi.org/10.25646/13622
Vancouver
Nübel J, Beyer AK, Kümpel L, Eckert G, Yessimova D, Heldt K, et al. Long COVID in adults – a current review of the long-term health effects following SARS-CoV-2 infection. RKI edoc (Robert Koch-Institut). 2026;11:1-14. doi:10.25646/13622
BibTeX
@article{Nbel2026,
author = {Nübel, Julia and Beyer, Ann-Kristin and Kümpel, Lisa and Eckert, Grit and Yessimova, Dinara and Heldt, Katharina and Mikolajewska, Agata and Sarganas, Giselle},
title = {Long COVID in adults – a current review of the long-term health effects following SARS-CoV-2 infection},
journal = {RKI edoc (Robert Koch-Institut)},
year = {2026},
volume = {11},
pages = {1--14},
doi = {10.25646/13622}
}
EUVIMED